Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
47°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pmv Pharmaceuticals Inc
(NQ:
PMVP
)
1.630
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
19,244
Open
1.620
Bid (Size)
1.530 (1)
Ask (Size)
1.650 (45)
Prev. Close
1.630
Today's Range
1.620 - 1.640
52wk Range
1.400 - 3.470
Shares Outstanding
45,775,461
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
“Game-Changing Biotech Companies Making Waves: INBS, PMVP, TPST, OMGA, MRSN”
August 16, 2024
Via
AB Newswire
PMVP Stock Earnings: PMV Pharma Beats EPS for Q2 2024
August 08, 2024
PMVP stock results show that PMV Pharma beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-47.76%
-47.76%
1 Month
+10.14%
+10.14%
3 Month
+11.64%
+11.64%
6 Month
-22.38%
-22.38%
1 Year
-14.66%
-14.66%
More News
Read More
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
May 29, 2024
From
Foundation Medicine
Via
Business Wire
PMVP Stock Earnings: PMV Pharma Beats EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
Recap: PMV Pharma Q3 Earnings
November 09, 2023
Via
Benzinga
The Latest Analyst Ratings for PMV Pharma
May 17, 2023
Via
Benzinga
PMV Pharma: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 13, 2023
Via
Benzinga
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 13, 2023
Via
Benzinga
Precision Oncology PMV Pharmaceuticals Reveals Early Data From Cancer Study In Pretreated Patients
October 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 12, 2023
Via
Benzinga
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 09, 2023
Via
Benzinga
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
August 09, 2023
Via
Benzinga
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
August 09, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks That Hit 52-Week Lows On Friday
February 24, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
January 09, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Via
Benzinga
Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings
November 17, 2022
Via
Benzinga
PMV Pharma, Merck Ink Clinical Trial Collaboration For Combination Study In Solid Tumors
July 18, 2022
Via
Benzinga
79 Biggest Movers From Yesterday
June 08, 2022
Via
Benzinga
Halted Stocks: 9 Circuit Breaker Stocks That Have Been Halted on Tuesday
June 07, 2022
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
Via
Benzinga
77 Biggest Movers From Yesterday
June 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 31, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.